181 related articles for article (PubMed ID: 19582723)
21. Optimized autoantibody profiling on protein arrays.
O'Kane SL; O'Brien JK; Cahill DJ
Methods Mol Biol; 2011; 785():331-41. PubMed ID: 21901610
[TBL] [Abstract][Full Text] [Related]
22. Comparative proteomic profiling of the serum differentiates pancreatic cancer from chronic pancreatitis.
Saraswat M; Joenväärä S; Seppänen H; Mustonen H; Haglund C; Renkonen R
Cancer Med; 2017 Jul; 6(7):1738-1751. PubMed ID: 28573829
[TBL] [Abstract][Full Text] [Related]
23. Fibrinogen gamma overexpression in pancreatic cancer identified by large-scale proteomic analysis of serum samples.
Bloomston M; Zhou JX; Rosemurgy AS; Frankel W; Muro-Cacho CA; Yeatman TJ
Cancer Res; 2006 Mar; 66(5):2592-9. PubMed ID: 16510577
[TBL] [Abstract][Full Text] [Related]
24. Optimized normalization for antibody microarrays and application to serum-protein profiling.
Hamelinck D; Zhou H; Li L; Verweij C; Dillon D; Feng Z; Costa J; Haab BB
Mol Cell Proteomics; 2005 Jun; 4(6):773-84. PubMed ID: 15793073
[TBL] [Abstract][Full Text] [Related]
25. Evaluation and characterization of anti-RalA autoantibody as a potential serum biomarker in human prostate cancer.
Li J; Dai L; Lei N; Xing M; Li P; Luo C; Casiano CA; Zhang JY
Oncotarget; 2016 Jul; 7(28):43546-43556. PubMed ID: 27286458
[TBL] [Abstract][Full Text] [Related]
26. Proteomic classification of pancreatic adenocarcinoma tissue using protein chip technology.
Scarlett CJ; Smith RC; Saxby A; Nielsen A; Samra JS; Wilson SR; Baxter RC
Gastroenterology; 2006 May; 130(6):1670-8. PubMed ID: 16697731
[TBL] [Abstract][Full Text] [Related]
27. Serum autoantibodies as biomarkers for early cancer detection.
Tan HT; Low J; Lim SG; Chung MC
FEBS J; 2009 Dec; 276(23):6880-904. PubMed ID: 19860826
[TBL] [Abstract][Full Text] [Related]
28. Serum autoantibodies to pancreatic cancer antigens as biomarkers of pancreatic cancer in a San Francisco Bay Area case-control study.
Bracci PM; Zhou M; Young S; Wiemels J
Cancer; 2012 Nov; 118(21):5384-94. PubMed ID: 22517435
[TBL] [Abstract][Full Text] [Related]
29. Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry.
Yu KH; Rustgi AK; Blair IA
J Proteome Res; 2005; 4(5):1742-51. PubMed ID: 16212428
[TBL] [Abstract][Full Text] [Related]
30. Multianalyte profiling of serum cytokines for detection of pancreatic cancer.
Zeh HJ; Winikoff S; Landsittel DP; Gorelik E; Marrangoni AM; Velikokhatnaya L; Winans MT; Lee K; Moser A; Bartlett D; Lotze MT; Siegfried JM; Whitcomb D; Papacristou G; Slivka A; Bigbee WL; Lokshin AE
Cancer Biomark; 2005; 1(6):259-69. PubMed ID: 17192050
[TBL] [Abstract][Full Text] [Related]
31. A systematic review of serum autoantibodies as biomarkers for pancreatic cancer detection.
Dumstrei K; Chen H; Brenner H
Oncotarget; 2016 Mar; 7(10):11151-64. PubMed ID: 26840568
[TBL] [Abstract][Full Text] [Related]
32. Serum-autoantibodies for discovery of prostate cancer specific biomarkers.
Massoner P; Lueking A; Goehler H; Höpfner A; Kowald A; Kugler KG; Amersdorfer P; Horninger W; Bartsch G; Schulz-Knappe P; Klocker H
Prostate; 2012 Mar; 72(4):427-36. PubMed ID: 22012634
[TBL] [Abstract][Full Text] [Related]
33. Autoantibody signature for the serologic detection of ovarian cancer.
Anderson KS; Cramer DW; Sibani S; Wallstrom G; Wong J; Park J; Qiu J; Vitonis A; LaBaer J
J Proteome Res; 2015 Jan; 14(1):578-86. PubMed ID: 25365139
[TBL] [Abstract][Full Text] [Related]
34. Occurrence of autoantibodies to annexin I, 14-3-3 theta and LAMR1 in prediagnostic lung cancer sera.
Qiu J; Choi G; Li L; Wang H; Pitteri SJ; Pereira-Faca SR; Krasnoselsky AL; Randolph TW; Omenn GS; Edelstein C; Barnett MJ; Thornquist MD; Goodman GE; Brenner DE; Feng Z; Hanash SM
J Clin Oncol; 2008 Nov; 26(31):5060-6. PubMed ID: 18794547
[TBL] [Abstract][Full Text] [Related]
35. Autoantibodies as potential biomarkers for breast cancer.
Zhong L; Ge K; Zu JC; Zhao LH; Shen WK; Wang JF; Zhang XG; Gao X; Hu W; Yen Y; Kernstine KH
Breast Cancer Res; 2008; 10(3):R40. PubMed ID: 18460216
[TBL] [Abstract][Full Text] [Related]
36. Antibody microarray profiling reveals individual and combined serum proteins associated with pancreatic cancer.
Orchekowski R; Hamelinck D; Li L; Gliwa E; vanBrocklin M; Marrero JA; Vande Woude GF; Feng Z; Brand R; Haab BB
Cancer Res; 2005 Dec; 65(23):11193-202. PubMed ID: 16322270
[TBL] [Abstract][Full Text] [Related]
37. Proteomics-based identification of DEAD-box protein 48 as a novel autoantigen, a prospective serum marker for pancreatic cancer.
Xia Q; Kong XT; Zhang GA; Hou XJ; Qiang H; Zhong RQ
Biochem Biophys Res Commun; 2005 May; 330(2):526-32. PubMed ID: 15796914
[TBL] [Abstract][Full Text] [Related]
38. Using protein microarray to identify and evaluate autoantibodies to tumor-associated antigens in ovarian cancer.
Ma Y; Wang X; Qiu C; Qin J; Wang K; Sun G; Jiang D; Li J; Wang L; Shi J; Wang P; Ye H; Dai L; Jiang BH; Zhang J
Cancer Sci; 2021 Feb; 112(2):537-549. PubMed ID: 33185955
[TBL] [Abstract][Full Text] [Related]
39. High diagnostic accuracy of histone H4-IgG autoantibodies in systemic lupus erythematosus.
Vordenbäumen S; Böhmer P; Brinks R; Fischer-Betz R; Richter J; Bleck E; Rengers P; Göhler H; Zucht HD; Budde P; Schulz-Knappe P; Schneider M
Rheumatology (Oxford); 2018 Mar; 57(3):533-537. PubMed ID: 29267954
[TBL] [Abstract][Full Text] [Related]
40. Autoantibody signature in human ductal pancreatic adenocarcinoma.
Tomaino B; Cappello P; Capello M; Fredolini C; Ponzetto A; Novarino A; Ciuffreda L; Bertetto O; De Angelis C; Gaia E; Salacone P; Milella M; Nisticò P; Alessio M; Chiarle R; Giuffrida MG; Giovarelli M; Novelli F
J Proteome Res; 2007 Oct; 6(10):4025-31. PubMed ID: 17824682
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
